切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - SUMOylation - EZH1 - Angiotensin-Converting Enzymes (ACEs)

13件产品中的 1-10

页面
每页
清除全部
  1. CPI-169
    B4678 CPI-169
     1 Citation
    Target: EZH2|EZH1
    Summary: EZH2抑制剂
      ≥26.45 mg/mL
      insoluble in H2O
  2. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  3. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  4. Perindopril
    B1214 Perindopril
    中文名: 培哚普利
    Target: Angiotensin-Converting Enzymes (ACEs)
    Summary: ACE抑制剂
      Soluble in DMSO
  5. Benazepril HCl
    B2216 Benazepril HCl
    中文名: 盐酸贝那普利
    Target: Angiotensin-Converting Enzymes (ACEs)
    Summary: 血管紧张素转换酶(ACE)抑制剂
      ≥18.2 mg/mL
      ≥18.1 mg/mL
  6. MLN4924
    B1036 MLN4924
     5 Citation
    Target: NAE|Ubiquitin-activating Enzyme E1|SUMOylation
    Summary: NAE抑制剂
      ≥22.18 mg/mL
      insoluble in H2O
  7. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  8. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  9. UNC1999
    B1583 UNC1999
     2 Citation
    Target: EZH2|EZH1
    Summary: EZH2抑制剂
      ≥28.5 mg/mL
      insoluble in H2O
  10. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O

13件产品中的 1-10

页面
每页